Log In
BCIQ
Print this Print this
 

ActoBiotic for celiac disease

  Manage Alerts
Collapse Summary General Information
Company Intrexon Corp.
DescriptionActoBiotic delivering immunogenic antigens of gluten
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationCeliac disease
Indication DetailsTreat celiac disease
Regulatory Designation
PartnerGenten Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/23/2016

Undisclosed

0

Undisclosed

Get a free BioCentury trial today